Join
About Us
Search
Sign In
Science
Journals
Annual Meeting
Small Conferences
Science Webinars
Advocacy
Public Policy
Action Center
Advocacy Training Program
Science Outreach
Professional Development
Professional Development
Training
Job Board
Awards & Grants
Webinars
Education
Education
Accreditation
Exam
Teaching
Membership
Join/Renew
Student Chapters
Elections & Nominations
Belonging & Opportunity
Engagement
ASBMB Today member magazine
About ASBMB
Contact Us
Sign In
Results updated successfully.
Filters
Expand All
Search Filters:
Clear All
Source
Education
(0)
Journals
(0)
Advocacy
(1)
Membership
(0)
Professional development
(0)
Meetings and events
(0)
Webinars
(0)
Awards and grants
(0)
COVID-19 resources and news
(0)
Awards and grants
(0)
ASBMB Today Magazine
(4)
Date
ASBMB journals
Find more of what you're looking for in our journals:
Journal of Biological Chemistry
Molecular & Cellular Proteomics
Journal of Lipid Research
Displaying results 1-5 of
5
for "WA 0859 3970 0884 Ongkos Pasang Partisi Kaca Tempered 12mm Murah Salaman Kab Magelang"
Sort by:
Relevance
Date
Advocacy
ASBMB statement on President-elect Joseph Biden's announced science team
Jan. 15, 2021
President-elect Joseph Biden has raised the importance of science in the White House's policy-making.
ASBMB Today Article
A new angle
June 1, 2015
A rare brain tumor kills 250 children every year in North America. But the discovery of a mutation in an unexpected gene has given researchers new drug targets and brings hope that someday this cancer can be tamed.
ASBMB Today Article
A very delicate balance
Nov. 17, 2021
Could blocking lysosomal gatekeeper PIKfyve slow neurodegeneration?
ASBMB Today Article
Women in science take on sexual harassment
Sept. 1, 2018
As the #metoo movement reaches research labs, activists are asking universities, funding agencies and scientific societies to do more about science’s sexual harassment problem. .
ASBMB Today Article
Closing in on a cure
Sept. 1, 2019
With the rollout of exon-skipping drugs that cost $300,000 a year and researchers focused on delivering corrections using compacted genes and CRISPR–Cas9, what is the future of treating this most common form of muscular dystrophy.